Antibodies
Ended Purchase Order Awarded Last action
- Contract number
- 75N91020P00110
- Awardee
-
Abcam Inc. UEI CCKFL5P2M9X3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,000
Award facts
- Contract value 100% obligated
- $16,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Abcam Inc. for $16,000 on December 30, 2019, for antibodies, with performance in Cambridge, Massachusetts and a completion date of January 29, 2020. No set-aside applied. Firm fixed price.
Quick answers
Who was awarded contract 75N91020P00110?
75N91020P00110 was awarded to Abcam Inc. by National Cancer Institute (National Institutes of Health) on December 30, 2019.
How much is contract 75N91020P00110 worth?
The government has obligated $16,000 on 75N91020P00110.
Was contract 75N91020P00110 competed?
The extent of competition for 75N91020P00110 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award